SIGN IN
Email Address
Password

Forgot password?
REGISTER HERE >>

Breakthrough Cancer Pain Monographs


Breakthrough cancer pain (BTCP) is a common occurrence in cancer patients that can be treated by a number of immediate-release (IR) opioids, some of which are specifically labeled for this use (i.e., IR fentanyl). However, the predominant use of breakthrough pain products, particularly the IR fentanyls, is off-label for noncancer pain-related diagnoses. Based on the National Survey on Drug Use and Health, medications are commonly being misused and abused by patients and acquaintances of patients. Education is needed around the safe use of opioid analgesics and, more specifically, the IR fentanyl medications for BTCP. This educational program is specifically designed to support this objective.

Diagnosing Breakthrough Cancer Pain

1.00 / AMA PRA Category 1 Credit(s)TM
1.00 / CE for Nurses
1.00 / CE for Pharmacists
 

Treating Breakthrough Cancer Pain

1.00 / AMA PRA Category 1 Credit(s)TM
1.00 / CE for Nurses
1.00 / CE for Pharmacists
 

Setting Up Your Office Practice

0.50 / AMA PRA Category 1 Credit(s)TM
0.50 / CE for Nurses
0.50 / CE for Pharmacists
 

General Safe Opioid Prescribing

1.00 / AMA PRA Category 1 Credit(s)TM
1.00 / CE for Nurses
1.00 / CE for Pharmacists
 

Recognizing Misuse, Abuse, and Diversion

0.75 / AMA PRA Category 1 Credit(s)TM
0.75 / CE for Nurses
0.75 / CE for Pharmacists
 
Home | Browse By Disease | Browse By Specialty | Browse By Profession | About HME | Contact Us | Web Support

© 2013 Haymarket Media, Inc.

Your use of this website constitutes acceptance of Haymarket Medical Education's Privacy Policy and Terms & Conditions

Haymarket Medical Education